Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1819995
PUBLISHER: IMARC | PRODUCT CODE: 1819995
Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2025-2033
PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global acute myeloid leukemia therapeutics market size reached USD 1,343.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,461.4 Million by 2033, exhibiting a growth rate (CAGR) of 10.53% during 2025-2033.
Acute myeloid leukemia (AML) refers to a clonal malignancy leading to the rapid growth of abnormal cells. It primarily impacts the bone marrow and white blood cells (WBCs) and is characterized by the discoloration of skin, breathlessness, fatigue, high body temperatures, weight loss, bleeding gums and nosebleeds. Some of the commonly used AML therapies include chemo-, immuno-, targeted- and hormonal therapies and surgical procedures. These therapeutics are usually combined with stem cell transplants to increase the efficacy, minimize complications and strengthen the immune system of the body.
The increasing prevalence of leukemia across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such disorders, is also driving the market growth. AML is primarily caused by genetic mutations in the body that impacts the levels of blood cell production. In line with this, the widespread adoption of combination and targeted therapies and increasing awareness regarding the available alternatives for cancer treatment are also favoring the market growth. Additionally, the advent of improved immunotoxins, alkylating agents, monoclonal antibodies and multidrug-resistant modulators is another major growth-inducing factor. These therapeutics offer prolonged results, higher efficacy, early and accurate identification of leukemia cells and reduced chances of cancer relapse. Other factors, including extensive research and development (R&D) activities in the field of oncology, along with significant improvements in the existing healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
Breakup by Treatment Type:
- Cytarabine
- Anthracycline Drugs
- Alkylating Agents
- Anti-Metabolites
- Tyrosine Kinase Inhibitors
- Others
Breakup by Drug Type:
- Small Molecule Drugs
- Biopharmaceuticals
Breakup by Route of Administration:
- Oral
- Injectables
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbvie Inc., Amgen Inc., Bristol-Myers Squibb Company, Celgene, Roche Holding AG, Gilead Sciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
- How has the global acute myeloid leukemia therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global acute myeloid leukemia therapeutics market?
- What are the key regional markets?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the route of administration?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global acute myeloid leukemia therapeutics market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112025A3129
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Acute Myeloid Leukemia Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Treatment Type
- 6.1 Cytarabine
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Anthracycline Drugs
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Alkylating Agents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Anti-Metabolites
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Tyrosine Kinase Inhibitors
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Small Molecule Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Biopharmaceuticals
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Route of Administration
- 8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Injectables
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbvie Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Amgen Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Bristol-Myers Squibb Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Celgene
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 Roche Holding AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Gilead Sciences Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Novartis AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Pfizer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Sanofi S.A.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.10 Takeda Pharmaceutical Company Limited
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Abbvie Inc.
Product Code: SR112025A3129
List of Figures
- Figure 1: Global: Acute Myeloid Leukemia Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019-2024
- Figure 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 4: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Treatment Type (in %), 2024
- Figure 5: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Drug Type (in %), 2024
- Figure 6: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Route of Administration (in %), 2024
- Figure 7: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Region (in %), 2024
- Figure 8: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Acute Myeloid Leukemia Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Acute Myeloid Leukemia Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: North America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: North America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: United States: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: United States: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Canada: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Canada: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: China: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: China: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Japan: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Japan: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: India: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: India: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: South Korea: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: South Korea: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Australia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Australia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Indonesia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Indonesia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Europe: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Europe: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Germany: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Germany: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: France: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: France: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: United Kingdom: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: United Kingdom: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Italy: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Italy: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Spain: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Spain: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Russia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Russia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Latin America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Latin America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Brazil: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Brazil: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Mexico: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Mexico: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2024
- Figure 77: Global: Acute Myeloid Leukemia Therapeutics Industry: SWOT Analysis
- Figure 78: Global: Acute Myeloid Leukemia Therapeutics Industry: Value Chain Analysis
- Figure 79: Global: Acute Myeloid Leukemia Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Acute Myeloid Leukemia Therapeutics Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
- Table 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
- Table 4: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
- Table 5: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Acute Myeloid Leukemia Therapeutics Market: Competitive Structure
- Table 7: Global: Acute Myeloid Leukemia Therapeutics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.